Gene · 1645
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Allopregnanolone: Metabolism, Mechanisms of Action, and Its Role in Cancer. | Int J Mol Sci | 2022 | 36614002 | PubTator, text mining | PubMed |
| Why Do Dietary Flavonoids Have a Promising Effect as Enhancers of Anthracyclines? Hydroxyl Substituents, Bioavailability and Biological Activity. | Int J Mol Sci | 2022 | 36613834 | PubTator, text mining | PubMed |
| The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. | Cells | 2022 | 36611918 | PubTator, text mining | PubMed |
| Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen. | Front Oncol | 2022 | 36601474 | PubTator, text mining | PubMed |
| siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro. | Front Oncol | 2022 | 36591491 | PubTator, text mining | PubMed |
| Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases. | Front Immunol | 2022 | 36591262 | PubTator, text mining | PubMed |
| The sirtuin family in health and disease. | Signal Transduct Target Ther | 2022 | 36581622 | PubTator, text mining | PubMed |
| Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer. | Front Genet | 2022 | 36568375 | PubTator, text mining | PubMed |
| Exploiting Polyphenol-Mediated Redox Reorientation in Cancer Therapy. | Pharmaceuticals (Basel) | 2022 | 36558995 | PubTator, text mining | PubMed |
| Lipedema: Insights into Morphology, Pathophysiology, and Challenges. | Biomedicines | 2022 | 36551837 | PubTator, text mining | PubMed |
| Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma. | Cancers (Basel) | 2022 | 36551694 | PubTator, text mining | PubMed |
| ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. | Cell Death Dis | 2022 | 36550099 | PubTator, text mining | PubMed |
| The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma. | Front Oncol | 2022 | 36544710 | PubTator, text mining | PubMed |
| Stereoscopic view synthesis with progressive structure reconstruction and scene constraints. | PLoS One | 2022 | 36534690 | PubTator, text mining | PubMed |
| Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury. | Front Pharmacol | 2022 | 36532745 | PubTator, text mining | PubMed |
| Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study. | JMIR Form Res | 2022 | 36520526 | PubTator, text mining | PubMed |
| Biological and pharmacological roles of m6A modifications in cancer drug resistance. | Mol Cancer | 2022 | 36517820 | PubTator, text mining | PubMed |
| The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis. | Mol Ther Nucleic Acids | 2022 | 36514354 | PubTator, text mining | PubMed |
| Triazolyl- vs Pyridyl-Functionalized N-Heterocyclic Carbene Complexes: Impact of the Pendant N-Donor Ligand on Intramolecular C-C Bond Formation. | ACS Org Inorg Au | 2022 | 36510612 | PubTator, text mining | PubMed |
| The role of Neanderthal introgression in liver cancer. | BMC Med Genomics | 2022 | 36503519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1645/papers?page=15